Intravenous adriamycin and external radiation therapy for treatment of hepatocellular carcinoma
Medical Journal of Cairo University [The]. 1994; 62 (3): 683-87
en Inglés
| IMEMR
| ID: emr-33462
ABSTRACT
Twenty four patients with primary malignant hepatocellular carcinoma [PHC], treated with either external radiation therapy alone [group I], or external radiotherapy with Adriamycin [group II], were evaluated. The median survival was 8 months for group I and 6 months for group II. The partial response rate was 46% for group I and 45% for group II. Acute and subacute toxicities developed in group II patients. It was found that external radiation therapy alone can palliate primary hepatocellular carcinoma for a reasonable duration and single agent Adriamycin chemotherapy does not add any further improvement
Buscar en Google
Índice:
IMEMR (Mediterraneo Oriental)
Asunto principal:
Radioterapia
/
Doxorrubicina
/
Inyecciones Intravenosas
Idioma:
Inglés
Revista:
Med. J. Cairo Univ.
Año:
1994
Similares
MEDLINE
...
LILACS
LIS